BISvsRAYS
ProShares UltraShort Nasdaq Biotechnology against Global X Solar ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | RAYS | |
|---|---|---|
| Expense ratio | 0.95% | 0.50% |
| Assets | $1850.59T | $7286.40T |
| Net flow, 1 month | — | — |
| Net flow, 1 year | +$2K | — |
| Return, YTD | -38.6% | — |
| Return, 1 year | -53.1% | — |
| Avg daily volume | 9K | — |
| Holdings | 7 | 49 |
| Listed | Apr 9, 2010 | Sep 8, 2021 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS